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Abstract 
 
          Doxorubicin is a chemotherapeutic agent that causes a lot of side effects in high doses. Thus, 
combination with a co-chemotherapeutic agent which can increase its toxicity on cancer cells, is needed to 
reduce its therapeutic dose. Red betel leaves (Piper crocatum Ruiz & Pav.) have been known to contain 
flavonoids and alkaloids that have anticancer activity. This study was conducted to determine the cytotoxic 
effect and apoptosis induction of red betel leaves methanolic extract (RBM), doxorubicin (dox) and the 
combination of them on WiDr cells as model of colon cancer. RBM was extracted by soxhlet method using 
methanol. Cytotoxicity assay was performed using MTT assay for both single and combination treatments 
for 24 hours to determine IC50 and CI as their parameters. Apoptosis induction was analyzed by double 
staining method using ethidium bromide-acridine orange staining. Treatment of RBM and dox on WiDr cells 
for 24 hours showed cytotoxic activity with IC50 100 μg/mL and 1.6 μM respectively. Combination of RBM 
and dox performed synergism effect with CI<0.9 (p<0.05). Combination of RBM (12.5 μg/mL) and dox (0.4 
μM) increased the number of apoptosis cells compared to each single treatment. Based on this study, it can 
be concluded that red betel leaves methanolic extract is potential to be developed as a co-
chemotherapeutic agent of doxorubicin on colon cancer but still need further study to disclose the 
underlying molecular mechanisms. 
 
Keywords : Red betel leaves (Piper crocatum Ruiz & Pav.), doxorubicin, WiDr cells, co-chemotherapeutic   
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INTRODUCTION 
 
The incidence rate of colon cancer is 
predicted to increase as the population grows in both 
developing and developed countries (Siegel, et al., 
2014). Based on the data from Indonesian Ministry 
of Health (2015), colon and rectal cancer is ranked 
fourth of cancer deaths after lung, liver, and stomach 
cancer every year. Therefore, the best therapy was 
needed to improve the quality of life and prevent 
mortality of colon cancer patients. 
Doxorubicin is a chemotherapeutic agent that 
has broad-spectrum antitumor activity. This drug is 
often used in cancer therapies, one of them is in 
colon cancer treatment. However, the use of 
doxorubicin is limited because it can cause toxicity 
on normal cells, cardiotoxicity leading to heart 
failure (Ferreira, et al., 2008), hepatotoxicity (El-
Sayyad, et al., 2009), and chemoresistence (Riganti, 
et al., 2009) so the treatment becomes less effective. 
To overcome this problem, a co-chemotherapeutic 
agent is required to improve the effectiveness of 
doxorubicin. 
Based on previous research study, it is known 
that red betel extract (Piper crocatum Ruiz & Pav.) 
contains a number of active compounds including 
flavonoids, alkaloids, essential oils and tannins 
(Farida, et al., 2010). Piperine, the main alkaloid in 
Piper genus showed cytotoxic activity on several 
cancer cells. Piperine was reported to have cytotoxic 
activity  in  blood  cancer (CEM and  HL-60), 
melanoma cancer (B16), and colon cancer (HCT-8) 
(Bezerra, et al., 2005)    and     breast    cancer    cells   
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(T47D) (Widowati, et al., 2011).Piperine was also 
reported to inhibit the growth of HT-29 colon cancer 
cells by induction of apoptosis (Kim, et al., 2009). 
This study was conducted to develop an agent 
which could enhance the effectiveness of 
doxorubicin. Cytotoxic effect of doxorubicin, red 
betel leaves methanolic extract (RBM) and its 
combination was performed in vitro using WiDr 
cells. Observation of apoptosis was done by double 
staining method using ethidium bromide-acridine 
orange. The results of this study are expected to 
provide scientific evidence of RBM in improving the 
cytotoxicity effect of doxorubicin so that it can 
become the basis of utilization of red betel leaves as 
the a co-chemotherapeutic agent of doxorubicin in 
the treatment of colon cancer. 
 
MATERIALS AND METHODS 
 
Sample Preparation 
Simplicia of Piper crocatum Ruiz & Pav 
leaves were collected from Bina Agro Mandiri, Inc., 
Bantul, Yogyakarta, Indonesia, and were determined 
at Biological Pharmacy Laboratory, UGM.  An 
amount of simplicia were powdered and extracted 
by soxhlet with 400 mL methanol in 3 cycles 
soxhlet. Then, filtrate was dried using rotary 
evaporator on 40ºC. Identification of chemical 
compounds in RBM was determined by thin layer 
chromatography (TLC) using naringenin as positive 
control for flavonoid and piperine as positive 
control for alkaloid. 
 
Cell Culture 
WiDr colon cancer cells were obtained from 
Cancer Chemoprevention Research Center, Faculty 
of Pharmacy, Universitas Gadjah Mada. Cells were 
grown in Roswell Park Memorial Institute (RPMI) 
medium (Sigma) with 10% FBS (Sigma), sodium 
bicarbonate, 1.5% Penicilin-Streptomycin and 0.5% 
Fungizone (Gibco). 
 
Cell Viability Assay 
Cell viability assays were performed using 
MTT assay. WiDr cells were seeded in 96-well plate 
at a density of 13x103 cells/well and were incubated 
for 24 hours. Cells were treated with increasing 
concentrations  of  doxorubicin   (0.25,   0.50,   0.75,  
 
1.00, 1.25, 1.50, 1.75, 2.00 µM) and RBM (10, 30, 
50, 70, 90, 110, 130, and 150 µg/mL). After 24 hours 
of incubation, culture medium was removed and 
cells were washed with PBS (Sigma). Then cells 
were added 100 µL MTT (Sigma) 5 mg/mL diluted 
with culture medium in each well for 4 hours. The 
absorbance of each well was measured using ELISA 
reader at 595 nm (Bio-Rad). The single absorbance 
data converted into percentage of cell viability and 
will be used to determine of the IC50 value. 
Apoptosis Detection 
Apoptosis was detected using ethidium 
bromide (50 mg) and orange acridine (15 mg) 
reagents (EtBr-AO) (Sigma, Sigma-Aldrich Corp., 
St. Louis, MO, USA) dissolved in 1 mL of ethanol 
95%. WiDr cells (5x104 cells/well) were seeded on 
coverslips in 24-well plates until 50-60% confluent. 
Cells were then incubated with RBM alone, 
doxorubicin alone and their combination for 24 
hours at a temperature of 37ºC. At the end of 
incubation, culture medium was removed and cells 
were washed with PBS. Coverslips were placed into 
object-glass and added with 10 µL 1x working 
solution acridine orange-ethidium bromide (Sigma). 
Morphological features of apoptosis were identified 
using fluorescence microscope (Zeiss MC 80) at 
100x magnification. 
 
Data Analysis 
Absorbance data were obtained from viability 
assays then converted into a percentage of cell 
viability and log values. Inhibitory concentration 
(IC50) value calculation is performed by the logit 
method. Synergistic cytotoxicity was determined by 
calculating the interaction index (CI = Combination 
Index) between doxorubicin and RBM. The 
observation of apoptotic induction was conducted 
with qualitative approach by observing the specific 
morphological criteria, including condensation and 
fragmentation of chromatin, also formation of 
apoptotic bodies. Live cells show a normal green 
nucleus, early apoptotic cells a bright green nucleus 
with condensed or fragmented chromatin, late 
apoptotic cells show condensed and fragmented 
orange chromatin, and cells that have died from 
direct necrosis show a structurally normal orange 
nucleus (McGahon, et al., 1995). 
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RESULTS 
 
Cell Viability Assay  
Cell viability assay was done to determine the 
IC50 of RBM alone, doxorubicin alone and their 
combination on WiDr cells. A lower IC50 means a 
more potent cytotoxic activity against cancer cells. 
Doxorubicin (dox) shows cytotoxic effect on WiDr 
cells after 24 hour incubation with the IC50 value of 
1.6 µM, while RBM has the IC50 value of 100 
µg/mL (Fig. 1). The curves show that RBM and dox 
decrease the cell viability with dose dependent 
manner. In higher doses, more cells appear to 
morphological changes and the quantity of cells 
decreasing. Cell shrinkage may occur because the 
cytoskeleton of cells is cut into pieces so that the 
cell shape becomes irregular. It is a sign of cells 
heading for death. 
The administration of doxorubicin at 
concentrations of 0.25-2.00 µM (Fig. 1a) and RBM 
at concentrations of 10-150 µg/mL (Fig. 1b) are able 
to decrease the viability of WiDr cells. The IC50 
value of single treatment of doxorubicin and RBM 
was then used as a basis for determining the 
concentration for combination treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect single treatment of Dox and RBM on WiDr Cell’s Viability. WiDr cells with density (13x103 
cells/well) were treated by Dox and RBM in the concentration as indicated in the picture. Observations were 
made after treatment under an inverted microscope with magnification of 400x. (a) Morphology of WiDr cells 
after treatment of Dox (left side) and the cell viability profile at various concentrations of Dox (right side). (b) 
Morphology of WiDr cells after treatment of RBM (left side) and the cell viability profile at various concentrations 
of RBM (right side). The IC50 value performed triplicate and was calculated by using linear regression in three 
independent experiments (p<0.05). Description: Signs show normal WiDr cells, cells undergoing morphological 
changes. 
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Effects of combination of RBM and Dox on 
WiDr cell viability  
Cell viability assay in combination was also 
done to see the effectiveness of doxorubicin and 
RBM combination in inhibiting the growth of 
WiDr colon cancer cells. A synergistic 
combination demonstrates the ability of RBM to 
increase the sensitivity doxorubicin on WiDr cells. 
Increased sensitivity indicates increased efficacy of 
doxorubicin which can reduce treatment dose to 
obtain the same cytotoxic effect. 
The concentrations for combination 
treatment were dose 1/16, 1/8, 1/4, and 1/2 of IC50. 
Doxorubicin was administered on WiDr cells at 
concentrations of 0.1 µM; 0.2 µM; 0.4 µM; and 0.8 
µM, while RBM was given at a concentration of 
6.25 µg/mL; 12.5 µg/mL; 25 µg/mL; and 50 
µg/mL. Results show that the combination index 
(CI) values of all combinations are less than 1 
(Table 1), which means that all combinations show 
a significant synergism (Reynolds and Maurer, 
2005). Some concentration combinations can also 
reduce cell viability to lower than 50% (Table 2). 
The single treatment of RBM and 
doxorubicin proved to be capable of decreasing 
cell viability when compared to untreated/ control 
cells, meanwhile in the combined treatment of dox 
and  RBM  seen that the number of live cells is less 
than the single treatment at the same doses (Fig. 
2a). The observation of cell viability also showed 
that in some combination treatments decreased 
significantly the  number of  viable cells (Fig. 2b). 
From the combined treatment, RBM shows 
to increase the cytotoxicity of doxorubicin on 
WiDr colon cancer cells. The increase of 
cytotoxicity effect of doxorubicin and RBM 
combination need to be further investigated by 
apoptosis detection. RBM concentration 12.5 
µg/mL (1/8 IC50) and dox 0.4 µM (1/4 IC50) were 
then used for the observation of apoptosis 
detection by double staining method. These 
concentrations were chosen because the cell 
viability in this combination was close to 50%. 
Therefore, the cell count would be optimal for the 
observation of apoptosis detection. 
 
 
Table 1. Combination Index (CI) value of RBM and Dox combination 
Concentration 
of RBM 
(μg/mL) 
Concentration of Dox (μM) 
0.1 0.2 0.4 0.8 
  
IC50 
  
IC50 
  
IC50 
  
IC50 
6,25  
(  IC50 ) 
0.21 0.27 0.48 0.67 
12,5   
(  IC50 ) 
0.23 0.27 0.44 0.60 
25    
 (  IC50 ) 
0.37 0.40 0.51 0.68 
50    
 (  IC50 ) 
0.54 0.57 0.61 0.74 
 
Table 2. The cell viability percentages in some dose combinations 
Concent
ration of 
RBM 
(μg/mL) 
Concentration of Dox (μM) 
0 0.1 0.2 0.4 0.8 
0   
IC50 
  
IC50 
  
IC50 
  
IC50 
0 100 73.9 69 64.3 57.3 
6,25 
(  IC50 ) 
84.3 73.5 68.6 69.5 59.4 
12,5 
(  IC50 ) 
73.3 62.3 55.8 59.2 49.2 
25 
(  IC50 ) 
71.8 60.7 55.5 53.1 46.4 
50 
(  IC50) 
63.7 50.4 46.9 39.3 32.2 
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Figure 2. Effects of combination of RBM and Dox on WiDr cell viability. WiDr cells with density (13x103 cells/well) 
were treated by Dox and RBM in the concentration as indicated in the picture, then incubated for 24 hours. Cells 
viability were obtained from the conversion of absorbance values of formazan that formed by MTT treatment as 
described in the research procedure. (a)	 The morphological observation was using inverted microscope at 
magnification 400x. (b) The effect of RBM and Dox combination treatment on viability of WiDr cells (n = 3, 
p<0.05) (left side). The value of inhibition was expressed as percentages of cell viability. (c) The concentration 
combination of test compounds vs CI. Description: Signs             show normal cells,            cells undergoing 
morphological changes. 
	
	
	
Apoptosis Test using Double Staining 
Observation of apoptosis detection was 
performed on WiDr cells after single treatment of 
RBM 12.5 µg/mL, dox 0.4 µM, and its combination 
at the same concentration. From apoptosis detection, 
combination of RBM and dox are able to increase 
the number of apoptosis cells than their single 
treatments (Fig. 3). The green fluorescence indicates 
the viable cells while the orange-red fluorescence 
indicates the death cells. Apoptosis cells were 
indicated by occurrence of chromatin condensation 
and the orange-red apoptotic bodies. 
 
In single treatment of doxorubicin and RBM, 
some cells experienced early apoptosis that the 
membrane still has green fluorescence but the 
nucleus showed chromatin condensation. The 
highest incidence of apoptosis was in the 
combination treatment of doxorubicin and RBM 
which was characterized by a bright green nucleus 
with condensed or fragmented chromatin (early 
apoptosis) and condensed or fragmented orange 
chromatin (late apoptosis) (Fig. 3). From apoptosis 
detection, it shows that the combination of RBM and 
doxorubicin increase the number of apoptosis cells 
compared with their single treatments. 
 
 
 
Untreated cells Dox 0.4 μM RBM 12.5 μg/mL Dox 0.4 μM+RBM 12.5 μg/mL 
Dox 
(µM) 
RBM 
(µg/mL) 
Cell 
viability 
(%) 
RBM 
(µg/mL) 
Dox 
(µM) 
CI 
(a) The Morphological Observation 
(b)  (c)  
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Figure 3. Apoptosis detection of RBM and dox on WiDr cells. WiDr cells (5x104cells/well) were seeded on coverslips. 
The treatment was administered after 24 hours after the cell planting process, then cells was stained with acridine 
orange-ethidium bromide and observed under fluorosence microscope with 100x magnification. The apoptotic cells 
are indicated by dashed arrows colored white. From the figure it can be seen that in the combination treatment of 
dox 0.4 μM and RBM 12.5 μg/mL shows the number of cells experiencing apoptosis more than the single treatment. 
 
 
DISCUSSION 
 
The results show that red betel leaves 
methanolic extract (RBM) treatment for 24 hours 
incubation shows cytotoxic activity and apoptosis 
induction against WiDr cells. RBM has potential to 
be developed as a co-chemotherapeutic agent of 
doxorubicin because it contains some secondary 
metabolites including alkaloids and flavonoids that 
are known to have anticancer activities. Arishandy 
(2010) reported that flavonoids found in red betel 
leaves were flavonols, flavanones, isoflavones, and 
aurons. Fitriyani (2011) also reported that the result 
of flavonoid screening with Wilstater test showed an 
orange change which means that in methanolic 
extract of red betel leaves also contains flavon 
compound. 
A chemotherapeutic agent is expected to 
induce apoptosis on cancer cells. Single treatment of 
doxorubicin (dox) for 24 hours is able to 
demonstrate cytotoxic effect. The results of 
cytotoxic activity of each single treatment performed 
that doxorubicin shows IC50 values of 1.6 µM, while 
RBM shows IC50 values of 100 µg/mL. Increased 
concentration of RBM and dox followed by 
decreased cell viability which was indicating a dose 
dependent manner. The IC50 value of RBM 
(methanolic) on WiDr colon cancer cells in this 
study is smaller than the IC50 value of red betel 
leaves ethanolic extract on HeLa cervical cancer 
cells with the IC50 value of 266.01 µg/mL which was 
conducted by Suci, et al. (2013). RBM also shows 
more potent on WiDr colon cancer cells than on 4T1 
breast cancer cells which has the IC50 value of 120 
µg/mL (Zulharini, 2015). However, the IC50 value of 
RBM on WiDr colon cancer cells is greater than the 
IC50 value of red betel leaves methanolic extract on 
T47D breast cancer cells with 44.25 µg/mL 
(Wicaksono, et al., 2009). 
RBM has better potential cytotoxic activity 
when it is compared with other methanolic extracts 
on WiDr colon cancer cells. The methanolic extract 
of the Ficus septica Burm rhizome has an IC50 value 
of of 423.62 µg/mL (Istiqomah, 2015), and 
methanolic extract of Tegari (Dianella nemorosa 
Lam.) which has a larger IC50 value of 1871 µg/mL 
on WiDr colon cancer cells (Karim, 2014). Potent 
cytotoxic activity indicates that RBM is potential to 
be developed as a co-chemotherapeutic agent of 
doxorubicin in the treatment of colon cancer. 
The result of cell viability assay the RBM and 
dox combination with ratio 1/16, 1/8, 1/4, and 1/2 of 
IC50 for 24 hours incubation shows a stronger 
cytotoxic effect as well as induce apoptosis than 
their single treatments. All combinations also show a 
significant synergism with CI value of less than 1. 
Observation of apoptosis induction is done further to 
know the activity of RBM and doxorubicin 
combination. 
Apoptosis detection on WiDr colon cancer 
cells in combination dose RBM at 12.5 µg/mL (1/8 
IC50) and dox at 0.4 µM (1/4 IC50) shows able to 
increase the number of cells undergoing apoptosis 
compared to their single treatments. This is 
characterized by cell morphology with a bright 
green-orange due to chromatin condensation and the 
cells begin to experience blebbing membranes, so 
that ethidium bromide can enter the cells. The 
observation of apoptosis induction has similar 
pattern with the result of cell viability test using 
MTT assay that shows combination in both 
concentrations have cell viability of 59.2% (Table 
2). This may be happen because cells which 
experienced early apoptosis and towards death still 
Untreated cells Dox 0.4 μM RBM 12.5 μg/mL Dox 0.4 μM+RBM 12.5	μg/mL 
1212.5 μg/mL 
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have metabolic activities so these cells still able to 
reduce the salt of tetrazolium into formazan crystals. 
Therefore, it causes cells that have experienced early 
apoptosis still remaining visible as viable cells in the 
MTT assay.  
Doxorubicin can induce apoptosis either p53-
dependent or p53-independent. However, WiDr cells 
were used in this study characterized with 
overexpression of COX-2 and TS which had mutant 
p53 protein (Palozza, et al., 2005; Noguchi, et al., 
1979). Therefore, increased the cytotoxic effect of 
RBM and doxorubicin combination on WiDr colon 
cancer cells is possible through p53-independent 
apoptotic pathway. In p53-independent, doxorubicin 
triggers extrinsic apoptosis pathway by stimulating 
caspase-8 activation and PARP cleavage (Lee, et al., 
2002). 
Apoptosis induced by doxorubicin on WiDr 
cells is also possible through increased reactive 
oxygen species (ROS). The ROS pathway may 
activate apoptosis through p53-independent which 
increases Bax expression and decreases Bcl-2 
expression in cells without involving p53 protein 
(Tsang, et al., 2003). Besides that, the apoptotic 
induction ability of RBM on WiDr colon cancer 
cells is also possible because RBM contains 
flavonoids and alkaloids. In previous studies, 
flavonoid compound was reported to stimulate 
apoptosis through several mechanisms such as 
inhibition activity of DNA topoisomerase I/ II, 
modulation of signaling pathways, decreased 
expression of Bcl-2 and Bcl-XL genes, enhanced 
expression of Bax and Bak genes and activation 
endonuclease (Ren, et al., 2003). While alkaloid was 
known to affect expression of Bcl-2 protein, increase 
caspase activation, and induce apoptosis p53-
independent through inhibition of survivin (Kim, et 
al., 2009). The presence of alkaloid in RBM may 
activate p53-independent apoptotic pathway through 
inhibition of survivin that can maximize activation 
of caspase effectors. Therefore, RBM may lead to 
direct the death of WiDr colon cancer cells through 
apoptotic mechanism. 
All data obtained in this study indicate that 
RBM has cytotoxic activity against WiDr cells and 
its combination with doxorubicin shows a significant 
synergism and able induce apoptosis. However, 
further research is needed to disclose the underlying 
molecular mechanism and determine the active 
compound in RBM which is responsible for the 
mechanism of cytotoxic effect and apoptosis 
induction on WiDr colon cancer cells. 
 
CONCLUSION 
 
Based on these results, the cytotoxic effect of 
doxorubicin on WiDr colon cancer cells could be 
enhanced with the use of red betel leaves methanolic 
extract (RBM) as a co-chemotherapeutic agent. 
RBM also increase the apoptosis induction together 
with the use of doxorubicin. The use of RBM as a 
combination agent may also reduce the dose of 
doxorubicin and expected to reduce the risk of side 
effects of doxorubicin in colon cancer 
chemotherapy. 
 
REFERENCES 
 
Arishandy, D.N.A.T., 2010, Isolation and Identification 
of Flavonoid on Piper betel Leaf Extracts, 
Thesis, Technology and Science Institute of 
Malang, Malang.  
Bezerra, D.P., Pessoa, C., de Moraes, M.O., Silveira, 
E.R., Lima, M.A., Elmiro, F.J., et al., 2005, 
Antiproliferative Effects of Two Amides, 
Piperine and Piplartine from Piper Species, 
Z. Naturforsch., 60(7-8), 539-543.   
El-Sayyad, H.I., Ismail, M.F., Shalaby, F.M., Abou-El-
Magd, R.F., Fernando, A., Raj, M.R.G., et al., 
2009, Histopat-hological Effects of Cisplatin, 
Doxorubicin and 5-Flurouracil (5-FU) on 
the Liver of Male Albino Rats, Int. J. Biol. Sci., 
5(5), 466-473. 
Farida, R., Dewa, M., Titis, N. and Endrawati, T., 
2010, Manfaat Sirih Merah (Piper crocatum) 
sebagai Agen Anti Bakterial terhadap 
Bakteri Gram Positif dan Gram Negatif, 
Jurnal Kedokteran dan Kesehatan Indonesia, 
1(7), 10-25. 
Ferreira, A.L.A., Matsubara L.S. and Matsubara B.B., 
2008, Anthracycline-Induced Cardiotoxicity, 
Cardiovasc. Hematol. Agents Med. Chem., 
6(4), 278-281. 
Fitriyani, A., Winarti, L., Muslichah, S. and Nuri., 
2011, Uji anti Inflamasi Ekstrak Metanol 
Daun Sirih Merah (Piper crocatum Ruiz & 
Pav) pada Tikus Putih, Majalah Obat 
Tradisional, 16(1), 34-42.   
Wulandari, et al., 2018 
Indones. J. Cancer Chemoprevent., 9(1), 1-8 	
8 
	
Istiqomah, N., 2015, Sitotoksisitas Fraksi Potensial 
Daun Steril dan Fertil, Serta Rimpang Sisik 
Naga (Pyrrosia piloselloides [L.] M.G. Price.) 
terhadap Sel Kanker Payudara T47D dan 
Kolon Widr, Thesis, Universitas Gadjah Mada, 
Yogyakarta.    
Karim, A.,K., 2014, Studi Aktivitas dan Mekanisme 
Antikanker In Vitro Ekstrak Metanolik Daun 
Dianella nemorosa Lam. (Liliaceae), 
Dissertation, Universitas Gadjah Mada, 
Yogyakarta. 
Kementerian Kesehatan RI, 2015, Stop Kanker, 
Infodatin, Pusat Data dan Informasi, 
http://www.depkes.go.id/download.php?file...
kanker.pdf, Cited May 25, 2015. 
Kim, E.J., Park, H., Shin, M., Shin, H.K. and Park, 
J.H.Y., 2009, Induction of Apoptosis in HT-
29 Human Colon Cancer Cells by the 
Pepper Component Piperine, J. Korean Soc. 
Food Sci. Nutr., 38(4), 442-450.  
Lee, S., Baek., M., Kim, H., Ha, J. and Jeoung, D., 
2002, Mechanism of Doxorubicin-induced 
Cell Death and Expression Profile Analysis, 
Biotechnol. Lett., 24(14), 1147-1151.  
McGahon, A.J., Martin, S.J., Bissonnette, R.P., 
Mahboubi, M., Shi, Y., Mogil, R., et al, 1995, 
The End of the (Cell) Line: Methods for the 
Study of Apoptosis in Vitro in Cell Death, San 
Diego: Academic Press. 
Noguchi, P., Wallace, R., Johnson, J., Early, E.M., 
O’Brien, S. and Ferrone, S., 1979, 
Characterization of the WiDr: a Human 
Colon Carcinoma Cell Line, In Vitro, 15(6), 
401-408. 
Palozza, P., Serini, S., Maggiano, N., Giuseppe, T., 
Navarra, P. and Ranelletti, F.O., 2005, β-
Carotene Downregulates the Steady-State 
and Heregulin-a-Induced COX-2 Pathways 
in Colon Cancer Cells, J. Nutr., 135(1), 129-
136. 
Ren, W., Qiao, Z., Wang, H., Zhu, L., Zhang, L., Lu, 
Y., et al, 2003, Molecular basis of Fas and 
cytochrome c pathways of apoptosis 
induced by tartary buckwheat flavonoid in 
HL-60 cells, Methods Find. Exp. Clin. 
Pharmacol., 25(6), 431-436. 
Reynolds, C.P. and Maurer, B.J., 2005, Evaluating 
Response to Antineoplastic Drug 
Combinations in Tissue Culture Models, 
Methods Mol. Med., 110, 173-183.   
Riganti, C., Doublier, S., Viarisio, D., Miraglia, E., 
Pescarmona, G., Ghigo, D., et al., 2009, 
Artemisinin induces doxorubicin resistance 
in human colon cancer cells via calcium-
dependent activation of HIF-1alpha and P-
glycoprotein overexpression, Br. J. 
Pharmacol., 156(7), 1054-1066. 
Siegel, R., DeSantis, C. and Jemal, A., 2014, Colon 
Cancer Statistics 2014, C.A. Cancer J. Clin., 
64(2), 104-117. 
Suci, D., Kartika, Y., Kaswati, N.M.N., Septiani, A. 
and Filya, H., 2013, Aktivitas antikanker 
metabolit sirih merah (Piper crocatum) 
terhadap sel kanker serviks, 
http://repository.ipb.ac.id/handle/123456789
/74040, Cited May 25, 2015. 
Tsang, W.P., Chau, S.P.Y., Kong, S.K., Fung, K.P. and 
Kwok, T.T., 2003, Reactive Oxygen Species 
Mediate Doxorubicin Induced p53-
Independent Apoptosis, Life Sci., 73(16), 
2047-2058.   
Wicaksono, B.D., Handoko., Y.A., Arung, E.T., 
Kusuma, I.W., Yulia, D., Pancaputra, A.N., et 
al., 2009, Antiproliferative effect of 
methanol extract of Piper crocatum Ruiz & 
Pav leaves on human breast (T47D) cells in-
vitro, Trop. J. Pharm. Res., 8(4), 345-352. 
Widowati, W., Mozef, T., Risdian, C., Ratnawati, H., 
Tjahjani, S. and Sandra, F., 2011, The 
Comparison of Antioxidative and 
Proliferation Inhibitor Properties of Piper 
betle L., Catharanthus roseus [L] G.Don, 
Dendrophtoe petandra L., Curcuma mangga 
Val. Extracts on T47D Cancer Cell Line, Int. 
Res. J. Biochem. Bioinform., 1(2), 22-28. 
Zulharini, M.S., 2015, Penelusuran Potensi Antikanker 
Ekstrak Metanolik Daun Sirih Merah (Piper 
crocatum Ruiz & Pav) terhadap Sel Kanker 
Payudara Metastasis melalui Pengamatan Efek 
Sitotoksik dan Migrasi Sel, Thesis, Fakultas 
Farmasi Universitas Gadjah Mada, 
Yogyakarta.  
 
 
